Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another
- 21 February 2007
- journal article
- review article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 23 (4) , 671-682
- https://doi.org/10.1185/030079906x167327
Abstract
Background: Geographic transferability of economic evaluation data from one country to another has the potential to make a more efficient use of national and international evaluation resources. However, inappropriate transferability of economic data can provide misleading results and lead to an inefficient use of scarce health care resources.Objectives: The objective of this study was to review, summarize and categorize the literature on: (i) factors affecting the geographic transferability of economic evaluation data; and (ii) approaches which have either been proposed or used for transferability.Methods: A systematic literature review on transferability was conducted. Electronic databases, hand searching and bibliographic searching techniques were utilized. Inclusion criteria for the review included conceptual or empirical papers with mention of factors affecting, or approaches for, transferability of economic evaluation data across geographic locations. Exclusion criteria included papers publi...Keywords
This publication has 71 references indexed in Scilit:
- A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between CountriesPharmacoEconomics, 2004
- Design, Analysis and Presentation of Multinational Economic StudiesPharmacoEconomics, 2002
- Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/250??g vs Fluticasone Propionate 250??g in Adults and Adolescents with Asthma IV: ResultsPharmacoEconomics, 1999
- Pharmacoeconomic Evaluation in the Real WorldPharmacoEconomics, 1999
- Methodological Hurdles in Conducting Pharmacoeconomic AnalysesPharmacoEconomics, 1999
- Cost Effectiveness of Roxithromycin Versus Cefaclor in AustraliaPharmacoEconomics, 1995
- Cost Effectiveness of Antiviral Treatment with Zalcitabine plus Zidovudine for AIDS Patients with CD4+ Counts Less Than 300/??l in 5 European CountriesPharmacoEconomics, 1994
- Comparing Cost-Effectiveness Across CountriesPharmacoEconomics, 1994
- How cost-effective is breast cancer screening in different EC countries?European Journal Of Cancer, 1993
- Cost Effectiveness of Clinical Diagnosis, Venography, and Noninvasive Testing in Patients with Symptomatic Deep-Vein ThrombosisNew England Journal of Medicine, 1981